B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo therapy aims to improve leukemia treatment
Disease control Recruiting nowThis study is testing a new treatment approach for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). It combines standard chemotherapy with two targeted immunotherapy drugs, blinatumomab and inotuzumab ozogamicin, to see if this mix works better…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug combo aims to boost survival in tough childhood leukemia
Disease control Recruiting nowThis study tests whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy and immunotherapy can improve outcomes for children and young adults with high-risk B-cell acute lymphoblastic leukemia (B-ALL). Participants will receive standard treatment with…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Can we use less blood in leukemia care? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at whether giving blood transfusions only when hemoglobin drops below 7 gm/dL (instead of 9 gm/dL) is safe and keeps quality of life similar in leukemia patients. About 50 adults with acute leukemia or related cancers who had chemotherapy or a stem cell transplan…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC